Logo

Valiant Laboratories Share Price

Valiant Laboratories (INR)108.03-0.4   (-0.4%)

Exchange ScripsBSE543998NSEVALIANTLABISININE0JWS01017

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Valiant Laboratories Performance

Market performance
Open price110.19
High110.19
Volumes60299
Prev Close108.03
Low105.31
Closing date2025-01-10
Historical performance
1 Year High214.95
3 Year High214.95
5 Year High214.95
1 Year Low100.20
3 Year Low100.20
5 Year Low100.20

Valiant Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
469
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1467.8
Dividend Yield
Dividend Yield
N/A

Valiant Laboratories Investment Returns

1 Year
-35.5%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Valiant Laboratories Technicals

IndicatorsValueSignal
5-DMA108.79Bearish
10-DMA110.62Bearish
20-DMA112.7Bearish
50-DMA114.37Bearish
100-DMA115.79Bearish
200-DMA129.87Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters88877
Foreign Investors---------------
Domestic Investors88877
Public Investors1518114241149061581437427
Government---------------

Valiant Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Other Income9749
Operating Profit13400
Interest13
Depreciation2016
Profit Before Tax-8381
Consolidated Net Profit3290
Adjusted EPS---9

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Share Capital434326
Total Reserves1934679
Minority Interest------
Total Non-Current Liabilities767617
Total Liabilities34272130
Capital Work in Progress4267
Total Assets34272130

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Cash Flow from Operating Activities19561
Cash Flow from Investing Activities-1439-552
Cash Flow from Financing Activitie1524-9
Net Cash Inflow / Outflow105-1
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1467.8.
  • 3Y Stock Price CAGR of the stock is -36.5.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹13 Million.
  • The company generated revenue of ₹1821 Million in the previous financial year.

Valiant Laboratories

108.03-0.4   (-0.4%)

Investment Amount: ₹ 17715
Current Value: ₹ 10803
Performance: -39%
P/L: ₹ -6912
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month